Is Strattera a controlled substance?
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects millions of individuals worldwide. The symptoms of ADHD include inattention, impulsivity and hyperactivity, which can have a significant impact on a person’s daily life. Medications such as Strattera (atomoxetine) have been developed to help manage these symptoms. However, some individuals may wonder if strattera is a controlled substance.
In this article, we will discuss the classification and use of Strattera, as well as the potential risks and side effects associated with the medication. But, before this it is important to understand what a controlled substance is.
WHAT IS A CONTROLLED SUBSTANCE?
A controlled substance is a drug or chemical whose possession and use are regulated by a government, typically because it has the potential for abuse or addiction. These substances are classified into schedules based on their medical use, potential for abuse, and safety. Schedule (I) substances, such as heroin and LSD, have no accepted medical use and a high potential for abuse. Schedule (V) substances, such as cough medicine with codeine, have a lower potential for abuse and are available by prescription.
Examples of controlled substances include opioids (such as morphine and fentanyl), stimulants (such as cocaine and methamphetamine), depressants (such as barbiturates and benzodiazepines), and hallucinogens (such as LSD and psilocybin).
The possession, distribution, and manufacture of controlled substances are all strictly regulated by laws at the federal and state level. Penalties for violating these laws can range from fines and probation to long prison sentences, depending on the substance and the circumstances of the crime.
The use of controlled substances can also have significant negative effects on an individual’s health, including addiction, overdose, and death. It can also have negative impacts on the person’s life, such as losing job, family, friends, and facing legal issues.
In addition, the abuse of controlled substances can also have broader societal impacts, such as increased crime and healthcare costs, as well as strain on the criminal justice system. Because of the negative effects of controlled substance abuse, various organizations and agencies are working to prevent and treat addiction, as well as to increase public awareness of the dangers of these substances.
Controlled substance abuse is a serious problem that requires a multifaceted approach, including education, prevention, treatment, and law enforcement.
WHAT IS STRATTERA?
Strattera is a medication that belongs to a class of drugs known as selective norepinephrine reuptake inhibitors (SNRIs). It is used to treat ADHD in children, adolescents, and adults. The drug works by increasing the levels of norepinephrine, a neurotransmitter in the brain that is thought to be involved in attention and impulsivity. Strattera is available in both capsule and liquid form and is taken orally once or twice a day.
Strattera (atomoxetine) is a medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It was first approved by the US Food and Drug Administration (FDA) in 2002, and it is currently manufactured by the pharmaceutical company Eli Lilly and Company. Strattera is a non-stimulant medication, meaning that it does not contain amphetamines or other stimulants, which are the active ingredients in most other medications used to treat ADHD.
The development of Strattera began in the late 1980s, when Eli Lilly and Company began researching the potential use of the drug for the treatment of ADHD. The company conducted several studies on the safety and efficacy of the drug in both children and adults, and in 2001, the FDA granted approval for the use of Strattera in children and adolescents with ADHD. In 2002, the FDA expanded the approval to include adults with ADHD. Strattera became the first non-stimulant medication to be approved for the treatment of ADHD.
Strattera is generally well-tolerated, with the most common side effects being stomach pain, nausea, vomiting, constipation, and decreased appetite. Less common side effects include dizziness, dry mouth, and sleep problems. In rare cases, more serious side effects such as liver damage, suicidal thoughts, and increased blood pressure have been reported. Patients should contact their healthcare provider if they experience any unusual symptoms while taking Strattera.
CLASSIFICATION OF STRATTERA
Strattera is classified as a non-controlled substance by the United States Drug Enforcement Administration (DEA). This means that it is not considered to have a high potential for abuse and is not regulated by the DEA. However, Strattera is classified as a Schedule II controlled substance in Canada. This means that the drug is considered to have a high potential for abuse and is regulated by the Canadian government.
In European countries, it is classified as a prescription only medicine (POM) and it is available only by prescription. It is important to note that medication classification and availability can vary by country, and it is always best to check with your local health authorities for the most accurate information
IS STRATTERA A CONTROLLED SUBSTANCE?
Answering the main question, Strattera (atomoxetine) is a non-controlled medication and is classified as a non-stimulant medication for the treatment of attention-deficit/hyperactivity disorder (ADHD). It works by increasing the levels of norepinephrine, a neurotransmitter in the brain that is thought to be involved in regulating attention and impulse control. It can be prescribed and obtained through a prescription from a healthcare professional.
Strattera (atomoxetine) is a non-controlled medication, which means it is not a controlled substance and is not considered to have a high potential for abuse or dependence. It is classified as a non-stimulant medication for the treatment of attention-deficit/hyperactivity disorder (ADHD). Unlike stimulant medications, which work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain, Strattera works by selectively inhibiting the reuptake of norepinephrine, a neurotransmitter that is thought to be involved in regulating attention and impulse control.
This leads to an increase in the levels of norepinephrine in the brain, which can improve symptoms of ADHD such as inattention, impulsivity, and hyperactivity. Strattera is typically prescribed by a healthcare professional, such as a physician or psychiatrist, and can be obtained through a prescription. It may be used alone or in combination with other ADHD treatments, such as behavior therapy or other medications.
Strattera (atomoxetine) is a non-controlled medication that is used to treat attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, impulsivity, and hyperactivity. These symptoms can interfere with daily functioning, including academic or occupational performance, social interactions, and self-esteem.
Strattera is classified as a non-stimulant medication for the treatment of ADHD. Unlike stimulant medications, such as Ritalin (methylphenidate) and Adderall (amphetamine-dextroamphetamine), which work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain, Strattera works by selectively inhibiting the reuptake of norepinephrine, a neurotransmitter that is thought to be involved in regulating attention and impulse control. This leads to an increase in the levels of norepinephrine in the brain, which can improve symptoms of ADHD such as inattention, impulsivity, and hyperactivity.
The exact cause of ADHD is not fully understood, but research suggests that it may be related to imbalances in certain neurotransmitters in the brain, such as dopamine and norepinephrine. These neurotransmitters are responsible for transmitting messages between nerve cells, and imbalances in their levels can affect attention, impulse control, and other functions.
Strattera works by inhibiting the reuptake of norepinephrine, which means it blocks the action of a protein called the norepinephrine reuptake transporter. This protein is responsible for removing norepinephrine from the synapse (the space between nerve cells) after it has been released. By inhibiting the reuptake of norepinephrine, Strattera increases the levels of norepinephrine in the synapse, which can improve symptoms of ADHD.
Strattera is typically prescribed by a healthcare professional, such as a physician or psychiatrist, and can be obtained through a prescription. It is usually taken once or twice daily, with or without food. The usual starting dose for children and adolescents is 0.5 mg/kg/day, which can be increased gradually over several weeks to a target dose of 1.2 mg/kg/day. The usual starting dose for adults is 40 mg/day, which can be increased gradually over several weeks to a target dose of 80 mg/day. The maximum recommended dose is 100 mg/day.
The effectiveness of Strattera in treating ADHD has been established in several clinical trials. In one study, children and adolescents with ADHD who received Strattera had significantly greater improvements in symptoms of inattention, impulsivity, and hyperactivity compared to those who received a placebo (a dummy treatment). In another study, adults with ADHD who received Strattera had significantly greater improvements in symptoms of inattention and impulsivity compared to those who received a placebo.
Strattera is generally well-tolerated, but like all medications, it can cause side effects. The most common side effects of Strattera are stomach pain, nausea, vomiting, constipation, decreased appetite, and dizziness. These side effects are usually mild to moderate and go away after a few days. Rarely, some people may experience more serious side effects, such as allergic reactions, changes in mood or behavior, or liver problems. If you experience any unusual symptoms while taking Strattera, you should contact your healthcare provider right away.
Strattera is not considered to have a high potential for abuse or dependence. It is not a controlled substance and does not produce the same “high” or euphoria that can be associated with stimulant medications. However, as with any medication, it is important to take Strattera exactly as prescribed by your healthcare provider. Do not stop taking Strattera abruptly, as this can cause withdrawal symptoms such as nausea, vomiting, and fatigue. If you need to stop taking Strattera, your healthcare provider will gradually reduce your dose to minimize withdrawal symptoms.
It is important to note that Strattera is not recommended for use in children under 6 years of age, and its safety and effectiveness in this age group have not been established. In addition, Strattera should not be used in combination with a monoamine oxidase inhibitor (MAOI), a type of antidepressant medication, due to the risk of serious drug interactions. If you are currently taking an MAOI or have taken one in the past 14 days, you should not take Strattera.
USE OF STRATTERA
Strattera is used to treat ADHD in children, adolescents, and adults. It is typically used as a first-line treatment for ADHD, and is often used in conjunction with other treatments such as behavioral therapy. Strattera is not approved for use in children under the age of six and is not recommended for use in individuals with certain medical conditions, such as glaucoma, hypertension, or a history of tics. It is important to consult with a healthcare professional before starting Strattera to determine if it is an appropriate treatment option.
NATURAL ALTERNATIVE FOR STRATTERA
Notwithstanding, before you use any of these natural alternatives, it is necessary you seek your Doctor’s advice along with a prescription. So, apart from using Strattera, there are various alternative that can as well be used for the treatment of ADHD.
These alternatives includes;
- Behavioral therapy for both children and adults.
- Lifestyle and nerve calming exercise such as yoga and massage.
- Supplements such as vitamin C, Omega-3,iron, etc.
- Essential oils such as rosemary oil, lavender oil and vetiver.
- Eating a balance diet and also avoiding foods that contain some additives.
RISKS AND SIDE EFFECTS OF TAKING STRATTERA
Like all medications, Strattera can cause side effects. The most common side effects associated with Strattera include nausea, decreased appetite, stomach pain, and fatigue. Other potential side effects include dry mouth, constipation, and blurred vision. In rare cases, Strattera can also cause serious side effects such as changes in mood, suicidal thoughts, and liver damage. It is important to discuss any potential side effects with a healthcare professional before starting Strattera.
CONCLUSION
Strattera is a medication that is used to treat ADHD in children, adolescents, and adults. It is classified as a non-controlled substance by the DEA in the United States, but is a Schedule II controlled substance in Canada. Strattera can be an effective treatment for ADHD, but it is not recommended for use in certain individuals and can cause side effects. It is important to consult with a healthcare professional before starting Strattera to determine if it is an appropriate treatment option.
It is important to note that Strattera is a prescription drug and should be used only under the guidance of a healthcare professional. It is not recommended to share or use someone else’s medication, and Strattera should not be used recreationally. Patients must also be aware of the potential risks and side effects associated with the drug and should report any unusual symptoms or reactions to their doctor.